down arrow

Strides Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
607.45
24.75 (4.25%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
3,890.13
3,688.39
3,070.25
3,315.87
2,751.97
2,178.37
2,845.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,890.13
3,688.39
3,070.25
3,315.87
2,751.97
2,178.37
2,845.12
Raw Material Cost
1,151.14
1,441.68
1,090.93
1,390.42
1,020.35
1,002.05
847.50
Purchase of Finished goods
554.84
187.87
316.11
296.08
146.94
187.15
439.15
(Increase) / Decrease In Stocks
43.07
-2.67
95.28
-353.71
-44.81
-104.00
92.19
Employee Cost
737.05
732.02
646.91
550.15
442.56
329.44
434.05
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
0.00
0.00
0.00
629.95
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
821.65
899.30
941.13
798.10
671.03
521.42
0.00
Total Expenditure (Excl Depreciation)
3,307.75
3,258.21
3,090.36
2,681.04
2,236.07
1,936.06
2,442.84
Operating Profit (PBDIT) excl Other Income
582.38
430.18
-20.11
634.83
515.90
242.31
402.28
Other Income
39.70
90.33
131.99
51.43
53.11
40.84
88.32
Operating Profit (PBDIT)
622.08
520.51
111.88
686.26
569.01
283.15
490.60
Interest
280.22
261.14
176.74
150.07
155.72
79.29
196.24
Exceptional Items
-139.46
1.54
-243.83
43.35
-77.68
21.62
-43.58
Gross Profit (PBDT)
152.81
242.34
-308.69
579.54
335.61
225.48
250.78
Depreciation
213.64
243.25
233.01
206.29
173.70
117.39
154.03
Profit Before Tax
-60.83
-0.92
-541.70
373.26
161.91
108.09
96.75
Tax
29.11
-55.30
-178.26
31.65
11.33
-26.86
5.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-89.94
54.38
-363.44
341.61
150.58
134.95
91.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
49.59
18.57
0.00
13.94
-12.77
240.62
0.00
Net Profit
-40.35
72.95
-363.44
355.55
137.81
375.57
701.19
Share in Profit of Associates
-53.97
-285.28
-110.81
-97.82
-107.23
-45.70
-16.80
Minority Interest
23.70
9.70
14.04
10.71
5.80
-5.26
-19.87
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-70.62
-202.64
-460.21
268.44
36.38
324.61
664.52
Equity Capital
91.90
90.30
89.79
89.68
89.57
89.55
89.37
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
2,033.66
2,121.96
2,269.44
2,686.98
2,437.85
2,559.16
0.00
Earnings per share (EPS)
-3.37
-22.44
-51.25
29.93
4.06
36.25
74.36
Diluted Earnings per share
-7.77
-22.49
-51.28
29.92
4.06
36.24
74.23
Operating Profit Margin (Excl OI)
14.97%
11.66%
-0.65%
19.15%
18.75%
11.12%
14.14%
Gross Profit Margin
3.93%
6.57%
-10.05%
17.48%
12.2%
10.35%
8.81%
PAT Margin
-3.7%
-6.26%
-15.45%
7.35%
1.58%
4.1%
3.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 5.47% vs 20.13% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 65.15% vs 55.97% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 35.38% vs 2,239.13% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 7.31% vs 47.75% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Strides Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
3,890.13
10,334.77
-6,444.64
-62.36%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,890.13
10,334.77
-6,444.64
-62.36%
Raw Material Cost
1,151.14
1,853.52
-702.38
-37.89%
Purchase of Finished goods
554.84
1,409.85
-855.01
-60.65%
(Increase) / Decrease In Stocks
43.07
-53.67
96.74
180.25%
Employee Cost
737.05
2,274.73
-1,537.68
-67.60%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
821.65
2,315.28
-1,493.63
-64.51%
Total Expenditure (Excl Depreciation)
3,307.75
7,799.71
-4,491.96
-57.59%
Operating Profit (PBDIT) excl Other Income
582.38
2,535.06
-1,952.68
-77.03%
Other Income
39.70
280.86
-241.16
-85.86%
Operating Profit (PBDIT)
622.08
2,815.92
-2,193.84
-77.91%
Interest
280.22
33.53
246.69
735.73%
Exceptional Items
-139.46
0.00
-139.46
Gross Profit (PBDT)
152.81
2,782.39
-2,629.58
-94.51%
Depreciation
213.64
398.25
-184.61
-46.36%
Profit Before Tax
-60.83
2,384.14
-2,444.97
-102.55%
Tax
29.11
457.58
-428.47
-93.64%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-89.94
1,926.56
-2,016.50
-104.67%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
49.59
0.00
49.59
Net Profit
-40.35
1,926.56
-1,966.91
-102.09%
Share in Profit of Associates
-53.97
15.21
-69.18
-454.83%
Minority Interest
23.70
-28.87
52.57
182.09%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-70.62
1,912.90
-1,983.52
-103.69%
Equity Capital
91.90
40.06
51.84
129.41%
Face Value
10.00
1.00
0.00
Reserves
2,033.66
9,323.03
-7,289.37
-78.19%
Earnings per share (EPS)
-3.37
47.75
-51.12
-107.06%
Diluted Earnings per share
-7.77
47.68
-55.45
-116.30%
Operating Profit Margin (Excl OI)
14.97%
24.53%
0.00
-9.56%
Gross Profit Margin
3.93%
26.92%
0.00
-22.99%
PAT Margin
-3.70%
18.79%
0.00
-22.49%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 3,890.13 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 5.47% vs 20.13% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -70.62 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 65.15% vs 55.97% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 582.38 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 35.38% vs 2,239.13% in Mar 2023

Annual - Interest
Interest 280.22 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 7.31% vs 47.75% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.97%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023